A single high dose of idarubicin combined with high-dose ABA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University La Sapienza of Rome.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples